Meeting the early and late challenges of renal transplantation As presented at the 9th International Wyeth Transplantation Symposium, Vienna, Austria, 16th-17th March, 2009
Presentations
Session 1: Setting the scene
Where did we leave off in 2008? Conclusions from the 8th International symposium
Professor Graeme Russ
Queen Elizabeth Hospital, Adelaide, Australia
Immunoregulation and tolerance
Professor Mohamed H. Sayegh
Harvard Medical School, Boston, USA
Session 2: Reviewing the latest clinical evidence
New approaches to de novo immunosuppression and steroid elimination
Professor Yvon Lebranchu
University Hospital of Tours, France
Optimizing early de novo immunosuppression with sirolimus – experience in the USA
Dr Matthew R. Weir
University of Maryland Hospital, Baltimore, Maryland, USA
Session 3: mTOR: effects and side effects
mTOR and autosomal dominant polycystic kidney disease
Professor Rudolf P. Wüthrich
University Hospital, Zürich, Switzerland
mTor and diabetes -- what does the current evidence tell us?
Professor Josep M. Campistol Hospital Clinic, University of Barcelona, Spain
Regression of left ventricular hypertrophy in kidney transplant recipients – the potential role of mTOR
Dr Ernesto Paoletti
San Martino University Hospital, Genoa, Italy
Session 4: The clinical perspectives to take home
Workshop feedback and conclusions
Panellists:Professor Josep M. Campistol
Dr Fritz Diekmann
Dr Stuart M. Flechner
Professor Peter Friend
Professor Dr. Gert Mayer
Dr Rainer Oberbauer
Professor Graeme Russ
Dr Matthew R. Weir
Closing remarks and conclusions
Dr Stuart M. Flechner
Cleveland Clinic, Lerner College of Medicine, Cleveland, Ohio, USA